InvestorsHub Logo

LakeshoreLeo1953

07/08/19 10:46 AM

#200003 RE: Doc328 #199994

Lucid, fact driven responses are always appreciated on the MB.

McMagyar

07/08/19 11:28 AM

#200026 RE: Doc328 #199994

Ok
I appreciate the time to find..
I stand corrected..
Not that big of deal.

Yo hum..
Probably nothing..
Timing is just in case someday..

Move along..

Not

Steady_T

07/08/19 12:50 PM

#200052 RE: Doc328 #199994

Unlike some, I feel that a successful US Rett small 15 patient study will not cause enough of a rise in SP to justify using the shelf.



I'm interested in your thoughts on this. I would expect a successful Rett trial to be a validation of the overall approach that 2-73 is using to treat disease. As such I'd expect it to be looked upon as increasing the apparent odds of success of the other trials.

So, I'd expect an out sized response to a Rett success.

You apparently see the situation differently. Would you mind sharing you perspective on this?

FitzyP33

07/08/19 1:04 PM

#200057 RE: Doc328 #199994

This is very cool, enlightening data.

So, we will likely be diluted, it's just a question of how much.

After the initial hit on the stock on Friday and next few days wears off we could resume higher. The problem is that the way this S-3 is constructed every time Anavex goes to tap to shelf a new prospectus is filed and the stock will likely get hit again depending up what is going on. Absent any positive reasons for the raise the stock will get hit again. The cycle repeats until there is positive news associated with any raise.